Dexlansoprazole
- Product NDC
- 71335-3071
- 11-digit product format
- 713353071
- Labeler code
- 71335
- Product ID
- 71335-3071_fc47d0ec-8924-4944-8bb5-96368d9c2b06
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- dexlansoprazole
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA202666
- Marketing category
- ANDA
- Marketing start
- 2022-12-01
- Substance
- DEXLANSOPRAZOLE
- Active strength
- 30 mg/1
- Pharmacologic classes
- Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Dexlansoprazole
- Brand name suffix
- delayed release
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DEXLANSOPRAZOLE | 30 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | UYE4T5I70X |
| Rxcui | 833204 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71335-3071-1 | Dexlansoprazole delayed release | 30 in 1 BOTTLE | CAPSULE, DELAYED RELEASE | 30 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 71335-3071-1 | 71335307101 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-3071-1) | 2026-02-09 | No | No | Historical |